| NUVLNuvalent, Inc. | 17,248,450 | $1.77B |
| COGTCogent Biosciences, Inc. | 9,043,903 | $348.1M |
| PRAXPraxis Precision Medicines, Inc. | 963,351 | $310.4M |
| VTRSViatris Inc | 20,206,170 | $273.0M |
| UTHRUNITED THERAPEUTICS Corp | 457,000 | $271.0M |
| RVMDREVOLUTION MEDICINES, INC. | 2,297,000 | $223.4M |
| LRMRLarimar Therapeutics, Inc. | 35,606,974 | $160.2M |
| VERAVera Therapeutics, Inc. | 3,722,100 | $149.7M |
| IONSIONIS PHARMACEUTICALS INC | 1,979,669 | $148.7M |
| BCRXBIOCRYST PHARMACEUTICALS INC | 15,038,000 | $143.2M |
| INSPInspire Medical Systems Inc. | 2,703,238 | $139.4M |
| LEGNLegend Biotech Corp | 7,687,638 | $139.1M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 4,264,789 | $136.5M |
| ACHCAcadia Healthcare Company Inc. | 4,520,000 | $105.7M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 1,573,297 | $98.6M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 3,943,600 | $97.6M |
| INDVIndivior Pharmaceuticals, Inc. | 3,097,790 | $94.4M |
| XENEXenon Pharmaceuticals Inc. | 1,615,696 | $94.0M |
| PHVSPharvaris N.V. | 3,126,042 | $88.3M |
| SNDXSyndax Pharmaceuticals Inc | 3,779,900 | $88.3M |
| TNGXTango Therapeutics, Inc. | 4,146,813 | $86.8M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 1,019,813 | $85.6M |
| PFEPFIZER INC | 3,040,000 | $85.4M |
| NBIXNEUROCRINE BIOSCIENCES INC | 610,000 | $80.4M |
| DAWNDay One Biopharmaceuticals, Inc. | 3,723,131 | $79.8M |
| SVRASavara Inc | 13,569,000 | $74.1M |
| GMABGenmab A/S | 2,462,000 | $66.1M |
| LNTHLantheus Holdings, Inc. | 827,999 | $62.8M |
| SPRYARS Pharmaceuticals, Inc. | 7,503,812 | $60.3M |
| STOKStoke Therapeutics, Inc. | 1,823,500 | $59.4M |
| IDYAIDEAYA Biosciences, Inc. | 1,530,008 | $51.0M |
| BLTEBELITE BIO, INC | 304,013 | $48.5M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 851,556 | $48.1M |
| KYMRKymera Therapeutics, Inc. | 561,170 | $46.7M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 4,885,446 | $43.7M |
| IRONDisc Medicine, Inc. | 657,000 | $42.0M |
| SIONSionna Therapeutics, Inc. | 970,590 | $38.9M |
| GPCRStructure Therapeutics Inc. | 767,993 | $37.0M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 67,935 | $22.5M |
| TYRATyra Biosciences, Inc. | 549,000 | $21.0M |
| FHTXFoghorn Therapeutics Inc. | 4,394,367 | $21.0M |
| DRUGBRIGHT MINDS BIOSCIENCES INC. | 283,000 | $20.7M |
| CMPXCompass Therapeutics, Inc. | 3,606,000 | $19.1M |
| MNPRMonopar Therapeutics | 323,745 | $17.7M |
| KYTXKyverna Therapeutics, Inc. | 2,000,000 | $17.3M |
| SGPSpyGlass Pharma Inc. | 550,000 | $14.3M |
| BBNXBeta Bionics Inc. | 1,324,000 | $13.3M |
| TSHATaysha Gene Therapies, Inc. | 2,722,165 | $12.2M |
| CGEMCullinan Therapeutics, Inc. | 386,169 | $5.5M |
| ANNXAnnexon, Inc. | 583,913 | $3.2M |
| ALECAlector, Inc. | 1,055,192 | $2.3M |
| PHGEBiomX Inc. | 131,272 | $493K |
| MANEVeradermics Incorporated | 5,000 | $316K |
| PMVPPMV Pharmaceuticals, Inc. | 8,790 | $11K |
| MYGNMYRIAD GENETICS INC | 505 | $2K |